Sapheon Inc. is a privately held medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease. The company's current focus is on an advanced treatment option for venous reflux (saphenous vein) disease, a $1 billion worldwide market. Sapheon has fully developed and obtained European Union regulatory approval for the VenaSeal™ Sapheon Closure System.
